Thursday, August 4, 2011

08/03/11 BMY, CIM, CSCO, EPB, EPD, HRB, JPM, SFL, TEG

BMY, CIM, CSCO, EPB, EPD, HRB, JPM, SFL, TEG

This analysis was performed throughout the day of August 3, 2011.
This was a volatile day and required re-pricing most of the trades at the time of execution to insure accurate pricing.

Symbol Name


BMY Bristol-Myers Squibb Company - 4.6% yield, Mid-high RVI's.

CIM Chimera Investment Group - 16.7% dividend, need I say more?

CSCO Cisco Systems, Inc - We are split internally on owning this stock. The RVI's are really low as the stock has underperformed so well. We question our decision to own this stock and are trying to get stopped out of our position.

EPB El Paso Pipeline Partners, LP - 5.5% dividend and mid-high RVI's.

EPD Enterprise Products Partners LP - 5.8% dividend and mid-high RVI's.

HRB H&R Block, Inc. - Overall #1 in this group although placing #2 in both SSR and Days Earnings - RVI's are mid, the P/E is low and the dividend is high.

JPM JP Morgan Chase & Co - We are hoping to get stopped out of this position. Banks are problematic to us and we are worried about this sector.

SFL Ship Finance International - #2 overall of the group - We struggles with this stock today - there is no apparent reason for its movement unless someone is trading on inside information - daily volume was 2-1/2 times normal and the stock took off strongly from its lows. The dividend is nearly 10%! We added to our position - RVI's are below 5%!

TEG Integrys Energy Group, Inc - #3 overall of the group - we went for the Sept option to try to capture the dividend. RVI's are low mid, the dividend is 5.4%.


*Note: the tables shown are embedded .jpg files. This means that you can: 1) double left click them with your mouse to enlarge them, or 2) right click them with your mouse and choose to open them in a new window or tab, print, save, etc.As with everything we post, we may or may not have the stock and/or strategy in place in any one of our portfolios or may add it at any time. We do not make any buy or sell recommendations. We provide basic analytical research, some short commentary of the results and encourage you to do your own thorough due diligence prior to any purchase or sale.











































































































































































No comments:

Post a Comment